GNFT GENFIT S.A. ADRs

Develops biopharmaceutical products for the treatment of cardio metabolic and neurodegenerative diseases This is an ADR of a company whose stock trades outside of the U.S. as the symbol FP:GNFT.

$3.99  +0.16 (4.05%)
As of 09/28/2022 15:46:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  France
Country of incorporation:  
IPO date:  01/27/2016
Outstanding shares:  49,815,489
Average volume:  46,249
Market cap:   $188,800,703
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   -1.89
PB ratio:   1.59
PS ratio:   20.40
Return on equity:   -84.08%
Net income %:   -1,082.03%